Fabrinet (NYSE:FN) PT Raised to $185.00

Fabrinet (NYSE:FN – Free Report) had its price objective upped by JPMorgan Chase & Co. from $174.00 to $185.00 in a research note published on Tuesday morning, Benzinga reports. They currently have an overweight rating on the technology company’s stock. A number of other equities analysts have also recently issued reports on FN. Needham & […]

Leave a Reply

Your email address will not be published.

Previous post UBS Group Boosts DraftKings (NASDAQ:DKNG) Price Target to $44.00
Next post Mirati Therapeutics (NASDAQ:MRTX) Downgraded by Leerink Partnrs